a Figure S1 . Effect of 17-oxo-DHA on FP-IC 50 of LPS-induced TNFα release in PBMCs from COPD patients and healthy controls and individual dose-response curves. PBMCs were treated with FP (10 -12 to 10 -7 M) or a combination of FP and 5 µM 17-oxo-DHA for 1h, and then stimulated with LPS for 18h. The levels of TNFα were measured in the supernatants by ELISA assay. (a) Individual values of IC 50 were calculated using the GraphPad software as the concentration of FP that produced 50% of the maximal inhibitory effect. In the samples where 17-oxo-DHA was added, it was not always possible to calculate IC 50 . In these specific cases, these values were not reported. (b-e) Individual dose-response curves that were used to calculate IC 50 values.
•, controls, FP; ○, controls, FP+17-oxo-DHA;
, COPD patients, FP; , COPD patients, FP+17-oxo-DHA. PBMCs were treated with FP (10 -12 to 10 -7 M) or a combination of FP and 5 µM 17-oxo-DHA for 1h, and then stimulated with LPS for 18h. The levels of IL-1β were measured in the supernatants by ELISA assay. (a) Individual values of IC 50 were calculated using the GraphPad software as the concentration of FP that produced 50% of the maximal inhibitory effect. In the samples where 17-oxo-DHA was added, it was not always possible to calculate IC 50 . In these specific cases, these values were not reported. (b-e) Individual dose-response curves that were used to calculate IC 50 values.
•, controls, FP; ○, controls, FP+17-oxo-DHA; , COPD patients, FP; , COPD patients, FP+17-oxo-DHA. PBMCs from COPD patients (empty bars, N=3) and healthy individuals (filled bars, N=3) were treated with 10 nM FP and 5 µM 17-oxo-DHA, alone or in combination, for 1h then stimulated with 1µg/ml LPS for 4 h. Total RNA was extracted and NLRP3 mRNA levels measured by RT-PCR. Mean with SEM are reported. Figure S4 . Effect of 17-oxo-DHA on NLRP3 inflammasome activation by ATP and MSU crystals. THP-1 cells were treated with 81 nM PMA for 48h then stimulated with 1 µg/ml LPS for 3.5 h, followed by FP (10 nM) or 17-oxo-DHA (10 µM) for 30 min then by 5 mM ATP for 30 min (a) or 150 µg/ml MSU crystals for 1h (b) in serum-free medium. IL-1β was measured in the supernatants by ELISA assay. Mean with SEM are reported. *, p-value <0.05; ns, p-value >0.05. Figure S5 . Effect of 17-oxo-DHA on AIM2 and NLRC4 inflammasomes activation and on caspase-1 activity. THP-1 cells were treated with 81 nM PMA for 48h then stimulated with 1 µg/ml LPS for 3.5 h, followed by FP (10 nM) or 17-oxo-DHA (10 µM) for 30 min then by 10 µg/ml flagellin from S. typhimurium (FLA-ST) for 1h (a) or 1 µg/ml dA-dT for 3h (b) in serum-free medium with lipofectamin 2000 (Lipo). IL-1β was measured in the supernatants by ELISA assay. (c) % Inhibition of caspase-1 activity by 17-oxo-DHA measured with an endpoint colorimetric enzymatic assay after 2 h. Mean with SEM are reported. *, p-value <0.05; ns, p-value >0.05. PBMCs isolated from healthy subjects were treated with increasing concentration of 17-oxo-DHA alone for 1h, then stimulated with 1 µg/ml LPS for 18h. The levels of TNFα were measured in the supernatants by ELISA assay. IC 50 and IC 25 values were calculated using the GraphPad software as the concentrations of 17-oxo-DHA that produced 50% and 25% of the maximal inhibitory effect, respectively. Data are reported as mean with SEM of 3 independent experiments. Figure S7 . Effect of increasing doses of FP alone or in combination with 2.5 µM 17-oxo-DHA on TNFα inhibition. PBMCs isolated from healthy subjects were treated with increasing concentrations of FP alone ( ) or in the presence of 2.5 µM 17-oxo-DHA ( ) for 1h, and then stimulated with LPS for 18h. The levels of TNFα were measured in the supernatants by ELISA assay. Data are reported as mean with SEM of 4 independent experiments (FP alone) or 3 independent experiments (FP+17-oxo-DHA).
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